Evaluación de ELISA de captura para NS1 como nueva herramienta del diagnóstico temprano de la infección por Dengue en Panamá.

[Evaluación de ELISA de captura para NS1 como nueva herramienta del diagnóstico temprano de la infección por Dengue en Panamá.]

Brechla Moreno Arévalo1



Publicado: 2014-03-02

Descargas

Resumen

Introducción. El dengue es una enfermedad infecciosa endémica en Panamá, por lo cual debemos tener un algoritmo de diagnóstico sensible y rápido para realizar un diagnóstico temprano, tomar decisiones eficaces y reducir el riesgo de complicaciones. La detección del antígeno NS1 por ELISA de captura puede ser efectiva en suero a partir del 1er día de fiebre hasta el 9no día, es fácil, rápida y menos costosa que otras metodologías diagnósticas.

Objetivo. Comparar la sensibilidad de una ELISA comercial de captura para NS1 con otros métodos diagnósticos de dengue utilizados en Panamá.

Materiales y Métodos. Se analizaron 138 sueros provenientes de la Ciudad de Panamá para diagnóstico de dengue por ELISAs comerciales de captura para NS1 e IgM, detección del genoma viral por RT-PCR en tiempo real y aislamiento viral en cultivo celular, y se compararon los resultados obtenidos por cada método.

Resultados. La ELISA de NS1 permite obtener un diagnóstico para dengue en menos de 6 horas. En este estudio se detectó más positivos para NS1 que la RT-PCR o aislamiento viral, incrementando la sensibilidad de la sola detección de IgM (57.4%) a una sensibilidad conjunta (IgM y NS1) de 87.23%.

Conclusión. La ELISA de NS1 en conjunto con la IgM ofrece una sensibilidad de detección de 87.23% y un diagnóstico precoz de dengue, lo que sugiere que la implementación de la ELISA NS1 en las instalaciones de salud en Panamá permita un diagnóstico rápido acertado.

Abstract

Introduction. Dengue is an infectious disease endemic in Panama, and for this reason we need a sensitive and fast algorythm to realize early diagnosis, make efficient decisions and reduce the risk of complications. The detection of the NS1 antigen by ELISA can be effective in serum since the first day of fever to the 9th day, and it is easier, faster and less expensive than other diagnostic methods.   Objective. To compare the detection sensibility of a commercial NS1 ELISA with other dengue diagnosis methods used in Panama.   Materials and Methods. 138 sera from Panama city were analyzed for dengue diagnosis by a commercial ELISAs to detect NS1 and IgM, detection of the viral genome by real time RT-PCR and viral isolation in cell culture; and the results obtained for each method were compared.   Results. The ELISA to detect NS1 can give diagnostic results in less than 6 hours. In this study it detected more dengue positive samples than by RT-PCR or virus isolation, increasing the sensibility of the sole detection of the IgM (57.4%) to a combined sensibility (IgM and NS1) of 87.23%.   Conclusion. The commercial NS1 ELISA combine with the IgM detection offers a sensibility of detection of 87.23% and an early diagnossis of dengue. This suggest that the implementation of the NS1 ELISA in the health facilities in Panama allows a fast and reliable diagnostic test.

Key words: dengue, diagnosis, NS1 (non structural protein1), NS1 capture ELISA, IgM, viral genome, RT-PCR, viral isolation, sensibility.


Abstract

Introducción. El dengue es una enfermedad infecciosa endémica en Panamá, por lo cual debemos tener un algoritmo de diagnóstico sensible y rápido para realizar un diagnóstico temprano, tomar decisiones eficaces y reducir el riesgo de complicaciones. La detección del antígeno NS1 por ELISA de captura puede ser efectiva en suero a partir del 1er día de fiebre hasta el 9no día, es fácil, rápida y menos costosa que otras metodologías diagnósticas.

Objetivo. Comparar la sensibilidad de una ELISA comercial de captura para NS1 con otros métodos diagnósticos de dengue utilizados en Panamá.

Materiales y Métodos. Se analizaron 138 sueros provenientes de la Ciudad de Panamá para diagnóstico de dengue por ELISAs comerciales de captura para NS1 e IgM, detección del genoma viral por RT-PCR en tiempo real y aislamiento viral en cultivo celular, y se compararon los resultados obtenidos por cada método.

Resultados. La ELISA de NS1 permite obtener un diagnóstico para dengue en menos de 6 horas. En este estudio se detectó más positivos para NS1 que la RT-PCR o aislamiento viral, incrementando la sensibilidad de la sola detección de IgM (57.4%) a una sensibilidad conjunta (IgM y NS1) de 87.23%.

Conclusión. La ELISA de NS1 en conjunto con la IgM ofrece una sensibilidad de detección de 87.23% y un diagnóstico precoz de dengue, lo que sugiere que la implementación de la ELISA NS1 en las instalaciones de salud en Panamá permita un diagnóstico rápido acertado.

Abstract

Introduction. Dengue is an infectious disease endemic in Panama, and for this reason we need a sensitive and fast algorythm to realize early diagnosis, make efficient decisions and reduce the risk of complications. The detection of the NS1 antigen by ELISA can be effective in serum since the first day of fever to the 9th day, and it is easier, faster and less expensive than other diagnostic methods.   Objective. To compare the detection sensibility of a commercial NS1 ELISA with other dengue diagnosis methods used in Panama.   Materials and Methods. 138 sera from Panama city were analyzed for dengue diagnosis by a commercial ELISAs to detect NS1 and IgM, detection of the viral genome by real time RT-PCR and viral isolation in cell culture; and the results obtained for each method were compared.   Results. The ELISA to detect NS1 can give diagnostic results in less than 6 hours. In this study it detected more dengue positive samples than by RT-PCR or virus isolation, increasing the sensibility of the sole detection of the IgM (57.4%) to a combined sensibility (IgM and NS1) of 87.23%.   Conclusion. The commercial NS1 ELISA combine with the IgM detection offers a sensibility of detection of 87.23% and an early diagnossis of dengue. This suggest that the implementation of the NS1 ELISA in the health facilities in Panama allows a fast and reliable diagnostic test.

Key words: dengue, diagnosis, NS1 (non structural protein1), NS1 capture ELISA, IgM, viral genome, RT-PCR, viral isolation, sensibility.

Citas

[1] Martina, B.E., P. Koraka, and A.D. Osterhaus, Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev, 2009. 22(4): p. 564-81.

[2] (WHO), W.H.O. and S.P.f.R.a.T.i.T.D. (TDR), Dengue: Guidelines for diagnosis, treatment, prevention and control. 2009: Geneva.

[3] Alvarez, M., et al., Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am J Trop Med Hyg, 2006. 75(6): p. 1113-7.

[4] Thein, S., et al., Risk factors in dengue shock syndrome. Am J Trop Med Hyg, 1997. 56(5): p. 566-72.

[5] Vaughn, D.W., et al., Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis, 2000. 181(1): p. 2-9.

[6] Wang, W.K., et al., Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis, 2006. 43(8): p. 1023-30.

[7] Weaver, S.C. and N. Vasilakis, Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol, 2009. 9(4): p. 523-40.

[8] Domingo-Carrasco, C. and J. Gascon-Bustrenga, [Dengue and other hemorrhagic viral fevers]. Enferm Infecc Microbiol Clin, 2005. 23(10): p. 615-26.

[9] Armien, B., et al., Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama. Am J Trop Med Hyg, 2008. 79(3): p. 364-71.

[10] Saavedra, G. and E. Quiroz, Diagnostico por laboratorio del dengue en Panamá. 1988-2004. Rev. Hosp Niño Panama, 2007. 23: p. 24-30.

[11] Kao, C.L., et al., Laboratory diagnosis of dengue virus infection: current and future perspectives in clinical diagnosis and public health. J Microbiol Immunol Infect, 2005. 38(1): p. 5-16.

[12] Saxena, P., et al., Development and evaluation of one step single tube multiplex RT-PCR for rapid detection and typing of dengue viruses. Virol J, 2008. 5: p. 20.

[13] Martin, D.A., et al., Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol, 2000. 38(5): p. 1823-6.

[14] Dussart, P., et al., Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vaccine Immunol, 2006. 13(11): p. 1185-9.

[15] Yabar V, C., Rol de las proteínas no estructurales en los eventos de replicación del ARN del virus dengue: propuesta de un modelo de replicación del ARN. Rev. perú. med. exp. salud. publica, 2003. 20(1): p. 51-57.

[16] Libraty, D.H., et al., High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis, 2002. 186(8): p. 1165-8.

[17] Hang, V.T., et al., Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses. PLoS Negl Trop Dis, 2009. 3(1): p. e360.

[18] Young, P.R., et al., An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol, 2000. 38(3): p. 1053-7.

[19] Alcon, S., et al., Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol, 2002. 40(2): p. 376-81.

[20] Lapphra, K., et al., Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness. Diagn Microbiol Infect Dis, 2008. 60(4): p. 387-91.

[21] Schilling, S., et al., Laboratory diagnosis of primary and secondary dengue infection. J Clin Virol, 2004. 31(3): p. 179-84.

[22] Leparc-Goffart, I., et al., Development and validation of real-time one-step reverse transcription-PCR for the detection and typing of dengue viruses. J Clin Virol, 2009. 45(1): p. 61-6.

[23] Kumarasamy, V., et al., Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection. Singapore Med J, 2007. 48(7): p. 669-73.

[24] Guzman, M.G., et al., Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis, 2010. 4(8).

[25] Duong, V., et al., Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis, 2011. 5(7): p. e1244.

[26] Bessoff, K., et al., Comparison of two commercially available dengue virus (DENV) NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for diagnosis of acute DENV infection. Clin Vaccine Immunol, 2008. 15(10): p. 1513-8.

[27] Tricou, V., et al., Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect Dis, 2010. 10: p. 142.

[28] Andries, A.C., et al., Field evaluation and impact on clinical management of a rapid diagnostic kit that detects dengue NS1, IgM and IgG. PLoS Negl Trop Dis, 2012. 6(12): p. e1993.

[29] Harris, E., et al., Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg, 2000. 63(1-2): p. 5-11.

[30] Rothman, A.L., Dengue: defining protective versus pathologic immunity. J Clin Invest, 2004. 113(7): p. 946-51.

[31] Huang, C.H., et al., Laboratory diagnostics of dengue fever: An emphasis on the role of commercial dengue virus nonstructural protein 1 antigen rapid test. J Microbiol Immunol Infect, 2012.

[32] Valdez Sandoval, J.J., et al., [Evaluation of the SD Dengue Duo diagnosis system for detection of NS1 protein and IgM and IgG dengue antibodies]. Rev Cubana Med Trop, 2012. 64(1): p. 27-34.

×